DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Meticillin is an investigational drug.
There have been 5 clinical trials for Meticillin. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2014.
The most common disease conditions in clinical trials are Peritonitis, Fibrosis, and Ascites. The leading clinical trial sponsors are Poitiers University Hospital, University of Padova, and Heidelberg University.
There are two US patents protecting this investigational drug and twenty-two international patents.
Recent Clinical Trials for Meticillin
|Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF Device||Centre Hospitalier Universitaire Dijon||Phase 2|
|Efficacy Study of Vitamin D Supplementation to Meticillin Resistant Staphylococcus Aureus (MRSA) Carriers||Peter Bergman||Phase 2|
|Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure||Poitiers University Hospital||Phase 3|
Top disease conditions for Meticillin
Top clinical trial sponsors for Meticillin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Meticillin||Start Trial||Phosphonate compounds for treatment of medical disorders||Achillion Pharmaceuticals, Inc. (New Haven, CT)||Start Trial|
|Meticillin||Start Trial||Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus||Seattle Genetics, Inc. (Bothell, WA)||Start Trial|
|Meticillin||Start Trial||Cyclic boronic acid ester derivatives and methods of making the same||Rempex Pharmaceuticals, Inc. (San Diego, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Meticillin||World Intellectual Property Organization (WIPO)||2017035357||2035-08-26||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|